468 related articles for article (PubMed ID: 15790460)
21. A novel selective progesterone receptor modulator asoprisnil (J867) down-regulates the expression of EGF, IGF-I, TGFbeta3 and their receptors in cultured uterine leiomyoma cells.
Wang J; Ohara N; Wang Z; Chen W; Morikawa A; Sasaki H; DeManno DA; Chwalisz K; Maruo T
Hum Reprod; 2006 Jul; 21(7):1869-77. PubMed ID: 16613890
[TBL] [Abstract][Full Text] [Related]
22. [Radiation sensitizing effect of anti HPV16E6-ribozyme on cervical carcinoma cell line].
Rao ZG; Zhang JR; Zheng YF; Zhou H; Qu LH
Ai Zheng; 2002 Feb; 21(2):149-52. PubMed ID: 12479064
[TBL] [Abstract][Full Text] [Related]
23. The human papillomavirus type 18 E6 oncoprotein induces Vascular Endothelial Growth Factor 121 (VEGF121) transcription from the promoter through a p53-independent mechanism.
Clere N; Bermont L; Fauconnet S; Lascombe I; Saunier M; Vettoretti L; Plissonnier ML; Mougin C
Exp Cell Res; 2007 Sep; 313(15):3239-50. PubMed ID: 17678892
[TBL] [Abstract][Full Text] [Related]
24. Dehydroepiandrosterone inhibits the proliferation and induces the death of HPV-positive and HPV-negative cervical cancer cells through an androgen- and estrogen-receptor independent mechanism.
Girón RA; Montaño LF; Escobar ML; López-Marure R
FEBS J; 2009 Oct; 276(19):5598-609. PubMed ID: 19702826
[TBL] [Abstract][Full Text] [Related]
25. Co-localization of the tumor-suppressor protein p53 and human papillomavirus E6 protein in human cervical carcinoma cell lines.
Liang XH; Volkmann M; Klein R; Herman B; Lockett SJ
Oncogene; 1993 Oct; 8(10):2645-52. PubMed ID: 8397367
[TBL] [Abstract][Full Text] [Related]
26. [Effect of anti-HPV16 E6-ribozyme on cell proliferation and invasiveness of cervical carcinoma cell line CaSKi].
Liu K; Wang LL; Sun F; Zheng YF; Zhang JR
Di Yi Jun Yi Da Xue Xue Bao; 2004 Dec; 24(12):1367-72. PubMed ID: 15604060
[TBL] [Abstract][Full Text] [Related]
27. Serum levels of insulin-like growth factor-I and -II and insulin-like growth factor binding protein 3 in women with squamous intraepithelial lesions and cervical cancer.
Serrano ML; Romero A; Cendales R; Sánchez-Gómez M; Bravo MM
Biomedica; 2006 Jun; 26(2):258-68. PubMed ID: 16925098
[TBL] [Abstract][Full Text] [Related]
28. Down-regulation of HPV18 E6, E7, or VEGF expression attenuates malignant biological behavior of human cervical cancer cells.
Chen L; Wu YY; Liu P; Wang J; Wang G; Qin J; Zhou J; Zhu J
Med Oncol; 2011 Dec; 28 Suppl 1():S528-39. PubMed ID: 21222176
[TBL] [Abstract][Full Text] [Related]
29. Adenoviral p53 effects and cell-specific E7 protein-protein interactions of human cervical cancer cells.
Choi JW; Ahn WS; Bae SM; Lee DB; Kim YW
Biosens Bioelectron; 2005 May; 20(11):2236-43. PubMed ID: 15797321
[TBL] [Abstract][Full Text] [Related]
30. Growth-regulating functions of human papillomavirus early gene products in cervical cancer cells acting dominant over enhanced epidermal growth factor receptor expression.
von Knebel Doeberitz M; Gissmann L; zur Hausen H
Cancer Res; 1990 Jun; 50(12):3730-6. PubMed ID: 1692767
[TBL] [Abstract][Full Text] [Related]
31. Chemoradiation of cervical cancer cells: targeting human papillomavirus E6 and p53 leads to either augmented or attenuated apoptosis depending on the platinum carrier ligand.
Koivusalo R; Krausz E; Ruotsalainen P; Helenius H; Hietanen S
Cancer Res; 2002 Dec; 62(24):7364-71. PubMed ID: 12499281
[TBL] [Abstract][Full Text] [Related]
32. [Effects of vascular endothelial growth factor on apoptosis of sinusoidal endothelial cells caused by ethanol: experiment with rats].
Zhang YJ; Xu L; Wang XD; Shi L; Wang ZF
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(44):3138-42. PubMed ID: 18269875
[TBL] [Abstract][Full Text] [Related]
33. Down-regulation of the insulin-like growth factor I receptor by antisense RNA can reverse the transformed phenotype of human cervical cancer cell lines.
Nakamura K; Hongo A; Kodama J; Miyagi Y; Yoshinouchi M; Kudo T
Cancer Res; 2000 Feb; 60(3):760-5. PubMed ID: 10676665
[TBL] [Abstract][Full Text] [Related]
34. Silencing of HPV 18 oncoproteins With RNA interference causes growth inhibition of cervical cancer cells.
Lea JS; Sunaga N; Sato M; Kalahasti G; Miller DS; Minna JD; Muller CY
Reprod Sci; 2007 Jan; 14(1):20-8. PubMed ID: 17636212
[TBL] [Abstract][Full Text] [Related]
35. Resistance of human cervical carcinoma cells to tumor necrosis factor correlates with their increased sensitivity to cisplatin: evidence of a role for DNA repair and epidermal growth factor receptor.
Nishikawa K; Rosenblum MG; Newman RA; Pandita TK; Hittelman WN; Donato NJ
Cancer Res; 1992 Sep; 52(17):4758-65. PubMed ID: 1380890
[TBL] [Abstract][Full Text] [Related]
36. Constitutively active Notch1 induces growth arrest of HPV-positive cervical cancer cells via separate signaling pathways.
Talora C; Cialfi S; Segatto O; Morrone S; Kim Choi J; Frati L; Paolo Dotto G; Gulino A; Screpanti I
Exp Cell Res; 2005 May; 305(2):343-54. PubMed ID: 15817159
[TBL] [Abstract][Full Text] [Related]
37. Regulation of insulin-like growth factor 1 binding protein 3 levels by epidermal growth factor and retinoic acid in cervical epithelial cells.
Andreatta-Van Leyen S; Hembree JR; Eckert RL
J Cell Physiol; 1994 Aug; 160(2):265-74. PubMed ID: 7518821
[TBL] [Abstract][Full Text] [Related]
38. RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53.
Sima N; Wang W; Kong D; Deng D; Xu Q; Zhou J; Xu G; Meng L; Lu Y; Wang S; Ma D
Apoptosis; 2008 Feb; 13(2):273-81. PubMed ID: 18060502
[TBL] [Abstract][Full Text] [Related]
39. Systemic levels contribute significantly to increased intraocular IGF-I, IGF-II and IGF-BP3 [correction of IFG-BP3] in proliferative diabetic retinopathy.
Spranger J; Bühnen J; Jansen V; Krieg M; Meyer-Schwickerath R; Blum WF; Schatz H; Pfeiffer AF
Horm Metab Res; 2000 May; 32(5):196-200. PubMed ID: 10871161
[TBL] [Abstract][Full Text] [Related]
40. IGF-1-induced VEGF and IGFBP-3 secretion correlates with increased HIF-1 alpha expression and activity in retinal pigment epithelial cell line D407.
Slomiany MG; Rosenzweig SA
Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2838-47. PubMed ID: 15277511
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
